Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.10.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Aug. 31, 2018
Nov. 30, 2017
CURRENT ASSETS:    
Cash and cash equivalents $ 16,741 $ 3,519
Restricted Cash 396 0
Accounts receivable, net 4,154 1,336
Prepaid expenses and other receivables 1,437 841
Receivables from related party 0 691
Grants receivable 267 183
Inventory 1,659 725
Total current assets 24,654 7,295
NON-CURRENT ASSETS:    
Bank deposits 91 0
Call option derivative 0 339
Investments in associates, net 0 1,321
Property and equipment, net 11,056 5,104
Intangible assets, net 17,576 15,051
Goodwill 15,632 10,684
Other assets 287 78
Total non-current assets 44,642 32,577
TOTAL ASSETS 69,296 39,872
CURRENT LIABILITIES:    
Accounts payable 2,962 3,914
Accrued expenses and other payables 811 1,435
Employees and related payables 2,312 2,961
Related parties 177 116
Advance payments on account of grant 2,619 1,719
Short-term loans and current maturities of long-term loans 661 378
Deferred income 4,863 3,611
Current maturities of convertible loans 358 2,780
Other 190 0
TOTAL CURRENT LIABILITIES 14,953 16,914
LONG-TERM LIABILITIES:    
Loans payable 1,800 2,118
Convertible loans 0 2,415
Retirement benefits obligation 430 6
Deferred taxes 2,979 690
Other 524 0
TOTAL LONG-TERM LIABILITIES 5,733 5,229
TOTAL LIABILITIES 20,686 22,143
COMMITMENTS 0 0
REDEEMABLE NON-CONTROLLING INTEREST 18,646 3,606
EQUITY:    
Common stock of $0.0001 par value, 145,833,334 shares authorized, 13,620,262 and 9,872,659 shares issued and outstanding as of August 31, 2018 and November 30, 2017, respectively 1 1
Additional paid-in capital 80,889 55,334
Receipts on account of shares to be allotted 5,490 1,483
Accumulated other comprehensive income 660 1,425
Accumulated deficit (57,415) (44,120)
Equity attributable to Orgenesis Inc. 29,625 14,123
Non-controlling interests 339 0
TOTAL EQUITY 29,964 14,123
TOTAL LIABILITIES AND EQUITY $ 69,296 $ 39,872